These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25323937)

  • 1. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status.
    Damasceno EA; Carneiro FP; Magalhães AV; Carneiro Mde V; Takano GH; Vianna LM; Seidler HB; Castro TM; Muniz-Junqueira MI; Amorim RF; Ferreira VM; Motoyama AB
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2163-8. PubMed ID: 25323937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L; Li HG; Xia ZS; Lü J; Peng TS
    Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Lee D; Yu EJ; Ham IH; Hur H
    Anticancer Res; 2017 Jan; 37(1):135-142. PubMed ID: 28011483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
    Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.
    Laboissiere RS; Buzelin MA; Balabram D; De Brot M; Nunes CB; Rocha RM; Cabral MM; Gobbi H
    BMC Gastroenterol; 2015 Nov; 15():157. PubMed ID: 26530403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival.
    Subasinghe D; Sivaganesh S; Samarsekera A; Kumarasinghe MP; Samarasekera DN; Lokuhetty MDS
    Dig Dis Sci; 2017 Sep; 62(9):2498-2510. PubMed ID: 28612195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.
    Liang JW; Zhang JJ; Zhang T; Zheng ZC
    Tumour Biol; 2014 May; 35(5):4849-58. PubMed ID: 24449506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 expression and its clinicopathological features in resectable gastric cancer.
    Kataoka Y; Okabe H; Yoshizawa A; Minamiguchi S; Yoshimura K; Haga H; Sakai Y
    Gastric Cancer; 2013 Jan; 16(1):84-93. PubMed ID: 22410801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    Cao GD; Chen K; Chen B; Xiong MM
    BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
    Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
    Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
    Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.
    Huang SC; Ng KF; Lee SE; Chen KH; Yeh TS; Chen TC
    Gastric Cancer; 2016 Jan; 19(1):176-82. PubMed ID: 25512144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis.
    Wang HB; Liao XF; Zhang J
    Medicine (Baltimore); 2017 Nov; 96(44):e8437. PubMed ID: 29095284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of HER2/neu expression in gastric cancer.
    Ananiev J; Gulubova M; Manolova I; Tchernev G
    Wien Klin Wochenschr; 2011 Jul; 123(13-14):450-4. PubMed ID: 21739203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.
    Aizawa M; Nagatsuma AK; Kitada K; Kuwata T; Fujii S; Kinoshita T; Ochiai A
    Gastric Cancer; 2014 Jan; 17(1):34-42. PubMed ID: 23430266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.